Al-Louzi Omar

Dr. Al-Louzi is a clinician-scientist with specialized training and expertise in conducting clinical and translational research in Multiple Sclerosis (MS) and Neuroimmunology, with a specific focus on identifying novel retinal and magnetic resonance imaging (MRI) biomarkers to track MS disease progression. The overarching goals of his research is to study the role of retinal degeneration in MS patients, with or without a history of optic neuritis, their relationship with global measures of brain atrophy, as well as anterior and posterior visual pathway injury. His work also involves understanding the central vein sign (CVS), an imaging biomarker with high specificity for MS, and its role in predicting clinical disability, as well as its histopathological correlates.